Latest News
Celsius Therapeutics Names Kassum as Chief Executive Officer
14 June 2019 - - US-based Celsius Therapeutics, a company translating single-cell genomic insights into precision therapeutics for patients with autoimmune diseases and cancer, has appointed Tariq Kassum, M.D., as president and chief executive office...
Concert Pharmaceuticals Reports Positive Results from Phase 1 Studies Evaluating CTP-692 in Healthy Volunteers
14 June 2019 - - US-based Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) has reported positive results from two studies in its Phase 1 programme evaluating CTP-692, a novel deuterium-modified form of D-serine being developed as an adjunctive treat...
Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma
14 June 2019 - - The US Food and Drug Administration has approved its PD-L1 IHC 22C3 pharmDx assay for expanded use, US-based Agilent Technologies Inc. (NYSE: A) said.
The assay is now approved as an aid in identifying patients with head a...
Senti Biosciences Names Fischer as New Independent Board Member
14 June 2019 - - Dr. Laurent Fischer has joined US-based gene circuit company Senti Biosciences as an independent member of its board of directors, the company said.
Fischer is currently senior vice president and head of the liver therapeutic a...
Seattle Genetics Makes Multiple Adcetris Presentations at the Congress of the European Hematology Association and the International Conference on Malignant Lymphoma
14 June 2019 - - US-based biotechnology company Seattle Genetics, Inc. (NASDAQ: SGEN) is presenting data from its Adcetris (brentuximab vedotin) clinical development programme at the 24th Annual Congress of the European Hematology Associati...